Obesity, metabolic syndrome, and primary hypertension.
Litwin M, Kułaga Z.
Pediatr Nephrol. 2021 Apr;36(4):825-837. doi: 10.1007/s00467-020-04579-3. Epub 2020 May 9.
Childhood Primary Hypertension: Not Uncommon, Not Benign.
Halbach SM, Flynn JT.
Hypertension. 2023 Jun;80(6):1197-1198. doi: 10.1161/HYPERTENSIONAHA.123.21041. Epub 2023 May 17.
Patients with uncontrolled hypertension or concomitant hypertension and benign prostatic hyperplasia.
Zusman R.
Clin Cardiol. 2004 Feb;27(2):63-9. doi: 10.1002/clc.4960270203.
Systolic hypertension in children: benign or beware?
Sorof JM.
Pediatr Nephrol. 2001 Jun;16(6):517-25. doi: 10.1007/s004670100586.
White Coat Hypertension: A Benign Finding or a Masked Risk Factor?
Kavian JA.
South Med J. 2023 Dec;116(12):962-963. doi: 10.14423/SMJ.0000000000001628.
Treatment of benign prostatic hyperplasia and hypertension in elderly hypertensive patients.
Suzuki H.
Br J Urol. 1998 Mar;81 Suppl 1:51-5. doi: 10.1046/j.1464-410x.1998.0810s1051.x.
'Benign' essential hypertension and kidney damage: a histopathologist's view.
Howie AJ.
J Hum Hypertens. 1996 Oct;10(10):691-4.
Examining the causal relationship between hypertension and benign paroxysmal vertigo: a univariate and multivariate Mendelian randomization study.
Wang L, Cui F, Chen X, Zhang Q, Yang J, Li S.
Acta Otolaryngol. 2025 May;145(5):400-408. doi: 10.1080/00016489.2025.2479015. Epub 2025 Mar 23.
Proteinuria and hypertension.
Ritz E, Nowicki M, Fliser D, Hörner D, Klimm HP.
Kidney Int Suppl. 1994 Nov;47:S76-80.
The epidemiology of benign prostatic hyperplasia and observations on concomitant hypertension.
Boyle P, Napalkov P.
Scand J Urol Nephrol Suppl. 1995;168:7-12.
